Melphalan in Patients With Neoplastic Meningitis
Completed · Phase 1
Conditions studied: Brain and Central Nervous System Tumors, Extragonadal Germ Cell Tumor, Leukemia, Lymphoma, Ovarian Cancer
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase I trial to study the effectiveness of melphalan in patients with persistent or recurrent neoplastic meningitis.
Key facts
- Study ID
- NCT00002750
- Run by
- Duke University
- People needed
- 6
- Starts
- 1992-12-01
- Expected to finish
- 2001-05-01
- Last updated by the study team
- 2013-02-20
Who can join
Age: 3 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Duke Comprehensive Cancer Center — Durham, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.